APO Research
Talk to an analyst

APO RESEARCH · REPORT

Female Oral Contraceptives

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Female Oral Contraceptives Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025194 pages

Choose your research edition.

Industry ResearchFemale Oral Contraceptives Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Female Oral Contraceptives Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Female Oral Contraceptives Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Female Oral Contraceptives Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Female Oral Contraceptives Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Female Oral Contraceptives market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Female Oral Contraceptives is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Female Oral Contraceptives is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Female Oral Contraceptives is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Female Oral Contraceptives is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Female Oral Contraceptives include Allergan,plc (Actavis), Mankind Pharma, Piramal Enterprises, Syzygy Healthcare, Bayer, Ferring B.V, Pfizer, Merck and Teva Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Female Oral Contraceptives market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Female Oral Contraceptives and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Female Oral Contraceptives sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Female Oral Contraceptives market size, projected growth trends, production technologies, key applications, and end-use industries.

Female Oral Contraceptives Segment by Company

Allergan,plc (Actavis)

Mankind Pharma

Piramal Enterprises

Syzygy Healthcare

Bayer

Ferring B.V

Pfizer

Merck

Teva Pharmaceutical

Janssen Global Services

Female Oral Contraceptives Segment by Type

Continuous Use Pill

Combination Pill

Progestin-only Pill

Female Oral Contraceptives Segment by Application

Online Sales

Offline Sales

Female Oral Contraceptives Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Female Oral Contraceptives market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Female Oral Contraceptives and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Female Oral Contraceptives.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Female Oral Contraceptives market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Female Oral Contraceptives manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Female Oral Contraceptives in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Female Oral Contraceptives in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Female Oral Contraceptives Industry Trends Table 2. Female Oral Contraceptives Industry Drivers Table 3. Female Oral Contraceptives Industry Opportunities and Challenges Table 4. Female Oral Contraceptives Industry Restraints Table 5. Global Female Oral Contraceptives Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Female Oral Contraceptives Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Female Oral Contraceptives Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Female Oral Contraceptives Sales Market Share by Manufacturers Table 9. Global Female Oral Contraceptives Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Female Oral Contraceptives Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Female Oral Contraceptives Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Female Oral Contraceptives Manufacturers, Product Type & Application Table 13. Global Female Oral Contraceptives Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Female Oral Contraceptives by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Continuous Use Pill Table 17. Major Manufacturers of Combination Pill Table 18. Major Manufacturers of Progestin-only Pill Table 19. Global Female Oral Contraceptives Sales by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Female Oral Contraceptives Sales by Type (2021-2026) & (k units) Table 21. Global Female Oral Contraceptives Sales by Type (2027-2032) & (k units) Table 22. Global Female Oral Contraceptives Sales Market Share by Type (2021-2026) Table 23. Global Female Oral Contraceptives Sales Market Share by Type (2027-2032) Table 24. Global Female Oral Contraceptives Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 25. Global Female Oral Contraceptives Revenue by Type (2021-2026) & (k units) Table 26. Global Female Oral Contraceptives Revenue by Type (2027-2032) & (k units) Table 27. Global Female Oral Contraceptives Revenue Market Share by Type (2021-2026) Table 28. Global Female Oral Contraceptives Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Online Sales Table 30. Major Manufacturers of Offline Sales Table 31. Global Female Oral Contraceptives Sales by Application 2021 VS 2025 VS 2032 (k units) Table 32. Global Female Oral Contraceptives Sales by Application (2021-2026) & (k units) Table 33. Global Female Oral Contraceptives Sales by Application (2027-2032) & (k units) Table 34. Global Female Oral Contraceptives Sales Market Share by Application (2021-2026) Table 35. Global Female Oral Contraceptives Sales Market Share by Application (2027-2032) Table 36. Global Female Oral Contraceptives Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 37. Global Female Oral Contraceptives Revenue by Application (2021-2026) & (k units) Table 38. Global Female Oral Contraceptives Revenue by Application (2027-2032) & (k units) Table 39. Global Female Oral Contraceptives Revenue Market Share by Application (2021-2026) Table 40. Global Female Oral Contraceptives Revenue Market Share by Application (2027-2032) Table 41. Global Female Oral Contraceptives Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 42. Global Female Oral Contraceptives Sales by Region (2021-2026) & (k units) Table 43. Global Female Oral Contraceptives Sales Market Share by Region (2021-2026) Table 44. Global Female Oral Contraceptives Sales Forecasted by Region (2027-2032) & (k units) Table 45. Global Female Oral Contraceptives Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Female Oral Contraceptives Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 47. North America Female Oral Contraceptives Sales by Country (2021-2026) & (k units) Table 48. North America Female Oral Contraceptives Sales by Country (2027-2032) & (k units) Table 49. Europe Female Oral Contraceptives Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 50. Europe Female Oral Contraceptives Sales by Country (2021-2026) & (k units) Table 51. Europe Female Oral Contraceptives Sales by Country (2027-2032) & (k units) Table 52. Asia Pacific Female Oral Contraceptives Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 53. Asia Pacific Female Oral Contraceptives Sales by Country (2021-2026) & (k units) Table 54. Asia Pacific Female Oral Contraceptives Sales by Country (2027-2032) & (k units) Table 55. South America, Middle East and Africa Female Oral Contraceptives Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 56. South America, Middle East and Africa Female Oral Contraceptives Sales by Country (2021-2026) & (k units) Table 57. South America, Middle East and Africa Female Oral Contraceptives Sales by Country (2027-2032) & (k units) Table 58. Global Female Oral Contraceptives Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Female Oral Contraceptives Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Female Oral Contraceptives Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Female Oral Contraceptives Revenue Market Share by Region (2021-2026) Table 62. Global Female Oral Contraceptives Revenue Market Share by Region (2027-2032) Table 63. Allergan,plc (Actavis) Company Information Table 64. Allergan,plc (Actavis) Business Overview Table 65. Allergan,plc (Actavis) Female Oral Contraceptives Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Allergan,plc (Actavis) Female Oral Contraceptives Product Portfolio Table 67. Allergan,plc (Actavis) Recent Development Table 68. Mankind Pharma Company Information Table 69. Mankind Pharma Business Overview Table 70. Mankind Pharma Female Oral Contraceptives Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Mankind Pharma Female Oral Contraceptives Product Portfolio Table 72. Mankind Pharma Recent Development Table 73. Piramal Enterprises Company Information Table 74. Piramal Enterprises Business Overview Table 75. Piramal Enterprises Female Oral Contraceptives Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Piramal Enterprises Female Oral Contraceptives Product Portfolio Table 77. Piramal Enterprises Recent Development Table 78. Syzygy Healthcare Company Information Table 79. Syzygy Healthcare Business Overview Table 80. Syzygy Healthcare Female Oral Contraceptives Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Syzygy Healthcare Female Oral Contraceptives Product Portfolio Table 82. Syzygy Healthcare Recent Development Table 83. Bayer Company Information Table 84. Bayer Business Overview Table 85. Bayer Female Oral Contraceptives Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Bayer Female Oral Contraceptives Product Portfolio Table 87. Bayer Recent Development Table 88. Ferring B.V Company Information Table 89. Ferring B.V Business Overview Table 90. Ferring B.V Female Oral Contraceptives Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Ferring B.V Female Oral Contraceptives Product Portfolio Table 92. Ferring B.V Recent Development Table 93. Pfizer Company Information Table 94. Pfizer Business Overview Table 95. Pfizer Female Oral Contraceptives Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Pfizer Female Oral Contraceptives Product Portfolio Table 97. Pfizer Recent Development Table 98. Merck Company Information Table 99. Merck Business Overview Table 100. Merck Female Oral Contraceptives Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Merck Female Oral Contraceptives Product Portfolio Table 102. Merck Recent Development Table 103. Teva Pharmaceutical Company Information Table 104. Teva Pharmaceutical Business Overview Table 105. Teva Pharmaceutical Female Oral Contraceptives Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Teva Pharmaceutical Female Oral Contraceptives Product Portfolio Table 107. Teva Pharmaceutical Recent Development Table 108. Janssen Global Services Company Information Table 109. Janssen Global Services Business Overview Table 110. Janssen Global Services Female Oral Contraceptives Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Janssen Global Services Female Oral Contraceptives Product Portfolio Table 112. Janssen Global Services Recent Development Table 113. Key Raw Materials Table 114. Raw Materials Key Suppliers Table 115. Female Oral Contraceptives Distributors List Table 116. Female Oral Contraceptives Customers List Table 117. Research Programs/Design for This Report Table 118. Authors List of This Report Table 119. Secondary Sources Table 120. Primary Sources List of Figures Figure 1. Female Oral Contraceptives Product Image Figure 2. Global Female Oral Contraceptives Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Female Oral Contraceptives Market Size (2021-2032) & (US$ Million) Figure 4. Global Female Oral Contraceptives Sales (2021-2032) & (k units) Figure 5. Global Female Oral Contraceptives Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Female Oral Contraceptives Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Continuous Use Pill Image Figure 9. Combination Pill Image Figure 10. Progestin-only Pill Image Figure 11. Global Female Oral Contraceptives Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Female Oral Contraceptives Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Female Oral Contraceptives Sales Market Share by Type (2021-2032) Figure 14. Global Female Oral Contraceptives Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 15. Global Female Oral Contraceptives Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Female Oral Contraceptives Revenue Market Share by Type (2021-2032) Figure 17. Online Sales Image Figure 18. Offline Sales Image Figure 19. Global Female Oral Contraceptives Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 20. Global Female Oral Contraceptives Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Female Oral Contraceptives Sales Market Share by Application (2021-2032) Figure 22. Global Female Oral Contraceptives Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Female Oral Contraceptives Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Female Oral Contraceptives Revenue Market Share by Application (2021-2032) Figure 25. North America Female Oral Contraceptives Sales and Growth Rate (2021-2032) & (k units) Figure 26. North America Female Oral Contraceptives Sales Market Share by Country (2021-2032) Figure 27. U.S. Female Oral Contraceptives Sales and Growth Rate (2021-2032) & (k units) Figure 28. Canada Female Oral Contraceptives Sales and Growth Rate (2021-2032) & (k units) Figure 29. Mexico Female Oral Contraceptives Sales and Growth Rate (2021-2032) & (k units) Figure 30. Europe Female Oral Contraceptives Sales and Growth Rate (2021-2032) & (k units) Figure 31. Europe Female Oral Contraceptives Sales Market Share by Country (2021-2032) Figure 32. Germany Female Oral Contraceptives Sales and Growth Rate (2021-2032) & (k units) Figure 33. France Female Oral Contraceptives Sales and Growth Rate (2021-2032) & (k units) Figure 34. U.K. Female Oral Contraceptives Sales and Growth Rate (2021-2032) & (k units) Figure 35. Italy Female Oral Contraceptives Sales and Growth Rate (2021-2032) & (k units) Figure 36. Netherlands Female Oral Contraceptives Sales and Growth Rate (2021-2032) & (k units) Figure 37. Asia Pacific Female Oral Contraceptives Sales and Growth Rate (2021-2032) & (k units) Figure 38. Asia Pacific Female Oral Contraceptives Sales Market Share by Country (2021-2032) Figure 39. China Female Oral Contraceptives Sales and Growth Rate (2021-2032) & (k units) Figure 40. Japan Female Oral Contraceptives Sales and Growth Rate (2021-2032) & (k units) Figure 41. South Korea Female Oral Contraceptives Sales and Growth Rate (2021-2032) & (k units) Figure 42. Southeast Asia Female Oral Contraceptives Sales and Growth Rate (2021-2032) & (k units) Figure 43. India Female Oral Contraceptives Sales and Growth Rate (2021-2032) & (k units) Figure 44. Australia Female Oral Contraceptives Sales and Growth Rate (2021-2032) & (k units) Figure 45. South America, Middle East and Africa Female Oral Contraceptives Sales and Growth Rate (2021-2032) & (k units) Figure 46. South America, Middle East and Africa Female Oral Contraceptives Sales Market Share by Country (2021-2032) Figure 47. Brazil Female Oral Contraceptives Sales and Growth Rate (2021-2032) & (k units) Figure 48. South Africa Female Oral Contraceptives Sales and Growth Rate (2021-2032) & (k units) Figure 49. Saudi Arabia Female Oral Contraceptives Sales and Growth Rate (2021-2032) & (k units) Figure 50. Turkey Female Oral Contraceptives Sales and Growth Rate (2021-2032) & (k units) Figure 51. Argentina Female Oral Contraceptives Sales and Growth Rate (2021-2032) & (k units) Figure 52. UAE Female Oral Contraceptives Sales and Growth Rate (2021-2032) & (k units) Figure 53. Egypt Female Oral Contraceptives Sales and Growth Rate (2021-2032) & (k units) Figure 54. Chile Female Oral Contraceptives Sales and Growth Rate (2021-2032) & (k units) Figure 55. Global Female Oral Contraceptives Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Female Oral Contraceptives Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Female Oral Contraceptives Revenue (2021-2032) & (US$ Million) Figure 58. North America Female Oral Contraceptives Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Female Oral Contraceptives Revenue (2021-2032) & (US$ Million) Figure 60. Europe Female Oral Contraceptives Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Female Oral Contraceptives Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Female Oral Contraceptives Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Female Oral Contraceptives Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Female Oral Contraceptives Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Female Oral Contraceptives Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Female Oral Contraceptives Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Continuous Use Pill
  • Combination Pill
  • Progestin-only Pill
Applications
  • Online Sales
  • Offline Sales
Companies covered
  • Allergan,plc (Actavis)
  • Mankind Pharma
  • Piramal Enterprises
  • Syzygy Healthcare
  • Bayer
  • Ferring B.V
  • Pfizer
  • Merck
  • Teva Pharmaceutical
  • Janssen Global Services

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Female Oral Contraceptives Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Female Oral Contraceptives Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Female Oral Contraceptives Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Female Oral Contraceptives Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Female Oral Contraceptives Market Dynamics
  1. 2.1 Female Oral Contraceptives Industry Trends
  2. 2.2 Female Oral Contraceptives Industry Drivers
  3. 2.3 Female Oral Contraceptives Industry Opportunities and Challenges
  4. 2.4 Female Oral Contraceptives Industry Restraints
3 Female Oral Contraceptives Market by Manufacturers
  1. 3.1 Global Female Oral Contraceptives Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Female Oral Contraceptives Sales by Manufacturers (2021-2026)
  3. 3.3 Global Female Oral Contraceptives Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Female Oral Contraceptives Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Female Oral Contraceptives Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Female Oral Contraceptives Manufacturers, Product Type & Application
  7. 3.7 Global Female Oral Contraceptives Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Female Oral Contraceptives Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Female Oral Contraceptives Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Female Oral Contraceptives Tier 1, Tier 2, and Tier 3
4 Female Oral Contraceptives Market by Type
  1. 4.1 Female Oral Contraceptives Type Introduction
  2. 4.1.1 Continuous Use Pill
  3. 4.1.2 Combination Pill
  4. 4.1.3 Progestin-only Pill
  5. 4.2 Global Female Oral Contraceptives Sales by Type
  6. 4.2.1 Global Female Oral Contraceptives Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Female Oral Contraceptives Sales by Type (2021-2032)
  8. 4.2.3 Global Female Oral Contraceptives Sales Market Share by Type (2021-2032)
  9. 4.3 Global Female Oral Contraceptives Revenue by Type
  10. 4.3.1 Global Female Oral Contraceptives Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Female Oral Contraceptives Revenue by Type (2021-2032)
  12. 4.3.3 Global Female Oral Contraceptives Revenue Market Share by Type (2021-2032)
5 Female Oral Contraceptives Market by Application
  1. 5.1 Female Oral Contraceptives Application Introduction
  2. 5.1.1 Online Sales
  3. 5.1.2 Offline Sales
  4. 5.2 Global Female Oral Contraceptives Sales by Application
  5. 5.2.1 Global Female Oral Contraceptives Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Female Oral Contraceptives Sales by Application (2021-2032)
  7. 5.2.3 Global Female Oral Contraceptives Sales Market Share by Application (2021-2032)
  8. 5.3 Global Female Oral Contraceptives Revenue by Application
  9. 5.3.1 Global Female Oral Contraceptives Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Female Oral Contraceptives Revenue by Application (2021-2032)
  11. 5.3.3 Global Female Oral Contraceptives Revenue Market Share by Application (2021-2032)
6 Global Female Oral Contraceptives Sales by Region
  1. 6.1 Global Female Oral Contraceptives Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Female Oral Contraceptives Sales by Region (2021-2032)
  3. 6.2.1 Global Female Oral Contraceptives Sales by Region (2021-2026)
  4. 6.2.2 Global Female Oral Contraceptives Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Female Oral Contraceptives Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Female Oral Contraceptives Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Female Oral Contraceptives Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Female Oral Contraceptives Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Female Oral Contraceptives Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Female Oral Contraceptives Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Female Oral Contraceptives Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Female Oral Contraceptives Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Female Oral Contraceptives Revenue by Region
  1. 7.1 Global Female Oral Contraceptives Revenue by Region
  2. 7.1.1 Global Female Oral Contraceptives Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Female Oral Contraceptives Revenue by Region (2021-2026)
  4. 7.1.3 Global Female Oral Contraceptives Revenue by Region (2027-2032)
  5. 7.1.4 Global Female Oral Contraceptives Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Female Oral Contraceptives Revenue (2021-2032)
  8. 7.2.2 North America Female Oral Contraceptives Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Female Oral Contraceptives Revenue (2021-2032)
  11. 7.3.2 Europe Female Oral Contraceptives Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Female Oral Contraceptives Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Female Oral Contraceptives Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Female Oral Contraceptives Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Female Oral Contraceptives Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Allergan,plc (Actavis)
  2. 8.1.1 Allergan,plc (Actavis) Company Information
  3. 8.1.2 Allergan,plc (Actavis) Business Overview
  4. 8.1.3 Allergan,plc (Actavis) Female Oral Contraceptives Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Allergan,plc (Actavis) Female Oral Contraceptives Product Portfolio
  6. 8.1.5 Allergan,plc (Actavis) Recent Developments
  7. 8.2 Mankind Pharma
  8. 8.2.1 Mankind Pharma Company Information
  9. 8.2.2 Mankind Pharma Business Overview
  10. 8.2.3 Mankind Pharma Female Oral Contraceptives Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Mankind Pharma Female Oral Contraceptives Product Portfolio
  12. 8.2.5 Mankind Pharma Recent Developments
  13. 8.3 Piramal Enterprises
  14. 8.3.1 Piramal Enterprises Company Information
  15. 8.3.2 Piramal Enterprises Business Overview
  16. 8.3.3 Piramal Enterprises Female Oral Contraceptives Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Piramal Enterprises Female Oral Contraceptives Product Portfolio
  18. 8.3.5 Piramal Enterprises Recent Developments
  19. 8.4 Syzygy Healthcare
  20. 8.4.1 Syzygy Healthcare Company Information
  21. 8.4.2 Syzygy Healthcare Business Overview
  22. 8.4.3 Syzygy Healthcare Female Oral Contraceptives Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Syzygy Healthcare Female Oral Contraceptives Product Portfolio
  24. 8.4.5 Syzygy Healthcare Recent Developments
  25. 8.5 Bayer
  26. 8.5.1 Bayer Company Information
  27. 8.5.2 Bayer Business Overview
  28. 8.5.3 Bayer Female Oral Contraceptives Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Bayer Female Oral Contraceptives Product Portfolio
  30. 8.5.5 Bayer Recent Developments
  31. 8.6 Ferring B.V
  32. 8.6.1 Ferring B.V Company Information
  33. 8.6.2 Ferring B.V Business Overview
  34. 8.6.3 Ferring B.V Female Oral Contraceptives Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Ferring B.V Female Oral Contraceptives Product Portfolio
  36. 8.6.5 Ferring B.V Recent Developments
  37. 8.7 Pfizer
  38. 8.7.1 Pfizer Company Information
  39. 8.7.2 Pfizer Business Overview
  40. 8.7.3 Pfizer Female Oral Contraceptives Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Pfizer Female Oral Contraceptives Product Portfolio
  42. 8.7.5 Pfizer Recent Developments
  43. 8.8 Merck
  44. 8.8.1 Merck Company Information
  45. 8.8.2 Merck Business Overview
  46. 8.8.3 Merck Female Oral Contraceptives Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Merck Female Oral Contraceptives Product Portfolio
  48. 8.8.5 Merck Recent Developments
  49. 8.9 Teva Pharmaceutical
  50. 8.9.1 Teva Pharmaceutical Company Information
  51. 8.9.2 Teva Pharmaceutical Business Overview
  52. 8.9.3 Teva Pharmaceutical Female Oral Contraceptives Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Teva Pharmaceutical Female Oral Contraceptives Product Portfolio
  54. 8.9.5 Teva Pharmaceutical Recent Developments
  55. 8.10 Janssen Global Services
  56. 8.10.1 Janssen Global Services Company Information
  57. 8.10.2 Janssen Global Services Business Overview
  58. 8.10.3 Janssen Global Services Female Oral Contraceptives Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Janssen Global Services Female Oral Contraceptives Product Portfolio
  60. 8.10.5 Janssen Global Services Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Female Oral Contraceptives Value Chain Analysis
  2. 9.1.1 Female Oral Contraceptives Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Female Oral Contraceptives Production Mode & Process
  6. 9.2 Female Oral Contraceptives Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Female Oral Contraceptives Distributors
  9. 9.2.3 Female Oral Contraceptives Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst